The Docking of Protein DPP4 and Drug Molecules for Type 2 Diabetes

Advances in Clinical Medicine
doi 10.12677/acm.2017.71004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hans Publishers

Related search

Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP4 Inhibitors for the Treatment of Type 2 Diabetes

English

Protein Biomarkers for the Prediction of Cardiovascular Disease in Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Screening for Type 2 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
1998English

Insulin-Like Growth Factor Binding Protein 2 (IGFBP-2) and the Risk of Developing Type 2 Diabetes

2019English

G-Protein-Coupled Receptors and Islet Function—Implications for Treatment of Type 2 Diabetes

Pharmacology and Therapeutics
Pharmacology
2007English

Computational Protein–ligand Docking and Virtual Drug Screening With the AutoDock Suite

Nature Protocols
BiochemistryGeneticsMolecular Biology
2016English

Lifestyle Intervention for Type 2 Diabetes Patients – Trial Protocol of the Copenhagen Type 2 Diabetes Rehabilitation Project

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2009English

Carbohydrate Substitution for Fat or Protein and Risk of Type 2 Diabetes in Male Smokers

European Journal of Clinical Nutrition
MedicineNutritionDietetics
2012English

Protein Tyrosine Phosphatase 1b (Ptp1b) in Obesity and Type 2 Diabetes

Acta Medica Saliniana
Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy